Development and Implementation of a Mobile Tool for High-Risk Pregnant Women to Deliver Effective Caregiving for Neonatal Abstinence Syndrome: Protocol for a Mixed Methods Study

Ekaterina Burduli, Hendrée E Jones, Olivia Brooks, Celestina Barbosa-Leiker, Ron Kim Johnson, John Roll, Sterling Marshall McPherson, Ekaterina Burduli, Hendrée E Jones, Olivia Brooks, Celestina Barbosa-Leiker, Ron Kim Johnson, John Roll, Sterling Marshall McPherson

Abstract

Background: The United States continues to experience an alarming rise in opioid use that includes women who become pregnant and related neonatal abstinence syndrome (NAS) in newborns. Most newborns experiencing NAS require nonpharmacological care, which entails, most importantly, maternal involvement with the newborn. To facilitate positive maternal-newborn interactions, mothers need to learn effective caregiving NAS strategies when they are pregnant; however, an enormous gap exists in the early education of mothers on the symptoms and progression of NAS, partly because no education, training, or other interventions exist to prepare future mothers for the challenges of caring for their newborns at risk for NAS.

Objective: In this paper, we describe a mixed methods, multistage study to adapt an existing mobile NAS tool for high-risk pregnant women and assess its usability, acceptability, and feasibility in a small randomized controlled trial.

Methods: Stage 1 will include 20 semistructured interviews with a panel of neonatology experts, NAS care providers, and mothers with experience caring for NAS-affected newborns to gather their recommendations on the management of NAS and explore their perspectives on the care of these newborns. The findings will guide the adaptation of existing mobile NAS tools for high-risk pregnant women. In stage 2, we will test the usability, acceptability, and feasibility of the adapted mobile tool via surveys with 10 pregnant women receiving opioid agonist therapy (OAT). Finally, in stage 3, we will randomize 30 high-risk pregnant women receiving OAT to either receive the adapted mobile NAS caregiving tool or usual care. We will compare these women on primary outcomes-maternal drug relapse and OAT continuation-and secondary outcomes-maternal-newborn bonding; length of newborn hospital stays; readmission rates; breastfeeding initiation and duration; and postpartum depression and anxiety at 4, 8, and 12 weeks postpartum.

Results: This project was funded in July 2020 and approved by the institutional review board in April 2020. Data collection for stage 1 began in December 2020, and as of January 2021, we completed 18 semistructured interviews (10 with NAS providers and 8 with perinatal women receiving OAT). Common themes from all interviews will be analyzed in spring 2021 to inform the adaptation of the NAS caregiving tool. The results from stage 1 are expected to be published in summer 2021. Stage 2 data collection will commence in fall 2021.

Conclusions: The findings of this study have the potential to improve NAS care and maternal-newborn outcomes and lead to commercialized product development. If effective, our new tool will be well suited to tailoring for other high-risk perinatal women with substance use disorders.

Trial registration: ClinicalTrials.gov NCT04783558; https://ichgcp.net/clinical-trials-registry/NCT04783558.

International registered report identifier (irrid): DERR1-10.2196/27382.

Keywords: mHealth; maternal child outcomes; neonatal abstinence syndrome; opioid use disorder.

Conflict of interest statement

Conflicts of Interest: SM and JR received research funding from the Bristol-Myers Squibb Foundation. SM received research funding from Ringful Health, LLC. SM also received research funding from Orthopedic Specialty Institute and consulted for the Consistent Care company. This funding was not related to the investigation reported here. None of the other authors have any financial, personal, or other type of relationship that would cause a conflict of interest that would inappropriately impact or influence the research and interpretation of the findings.

©Ekaterina Burduli, Hendrée E Jones, Olivia Brooks, Celestina Barbosa-Leiker, Ron Kim Johnson, John Roll, Sterling Marshall McPherson. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 15.04.2021.

Figures

Figure 1
Figure 1
Stage process and time line of study. NAS: neonatal abstinence syndrome; OAT: opioid agonist therapy.

References

    1. Dramatic increases in maternal opioid use and neonatal abstinence syndrome. National Institute on Drug Abuse. 2019. [2019-05-21]. .
    1. Patrick SW, Richards MR, Dupont WD, McNeer E, Buntin MB, Martin PR, Davis MM, Davis CS, Hartmann KE, Leech AA, Lovell KS, Stein BD, Cooper WO. Association of pregnancy and insurance status with treatment access for opioid use disorder. JAMA Netw Open. 2020 Aug 03;3(8):-. doi: 10.1001/jamanetworkopen.2020.13456.
    1. Short VL, Hand DJ, MacAfee L, Abatemarco DJ, Terplan M. Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States. J Subst Abuse Treat. 2018 Jun;89:67–74. doi: 10.1016/j.jsat.2018.04.003.
    1. Kocherlakota P. Neonatal abstinence syndrome. Pediatrics. 2014 Aug 28;134(2):547–61. doi: 10.1542/peds.2013-3524.
    1. Reid CN, Foti TR, Mbah AK, Hudak ML, Balakrishnan M, Kirby RS, Wilson RE, Sappenfield WM. Multilevel factors associated with length of stay for neonatal abstinence syndrome in Florida's NICUs: 2010-2015. J Perinatol. 2020 Sep 16; doi: 10.1038/s41372-020-00815-8.
    1. Winkelman TN, Villapiano N, Kozhimannil KB, Davis MM, Patrick SW. Incidence and costs of neonatal abstinence syndrome among infants with medicaid: 2004-2014. Pediatrics. 2018 Apr 23;141(4):-. doi: 10.1542/peds.2017-3520.
    1. Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery hospitalization - United States, 1999-2014. MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):845–9. doi: 10.15585/mmwr.mm6731a1. doi: 10.15585/mmwr.mm6731a1.
    1. Honein MA, Boyle C, Redfield RR. Public health surveillance of prenatal opioid exposure in mothers and infants. Pediatrics. 2019 Mar 17;143(3):-. doi: 10.1542/peds.2018-3801.
    1. Wachman EM, Schiff DM, Silverstein M. Neonatal abstinence syndrome: advances in diagnosis and treatment. J Am Med Assoc. 2018 Apr 03;319(13):1362–74. doi: 10.1001/jama.2018.2640.
    1. McQueen K, Murphy-Oikonen J. Neonatal abstinence syndrome. N Engl J Med. 2016 Dec 22;375(25):2468–79. doi: 10.1056/nejmra1600879.
    1. Finnegan L, Connaughton JJ, Kron R, Emich J. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975;2(1-2):141–58.
    1. Patrick SW, Burke JF, Biel TJ, Auger KA, Goyal NK, Cooper WO. Risk of hospital readmission among infants with neonatal abstinence syndrome. Hosp Pediatr. 2015 Oct 01;5(10):513–9. doi: 10.1542/hpeds.2015-0024.
    1. Witt CE, Rudd KE, Bhatraju P, Rivara FP, Hawes SE, Weiss NS. Neonatal abstinence syndrome and early childhood morbidity and mortality in Washington state: a retrospective cohort study. J Perinatol. 2017 Oct 6;37(10):1124–9. doi: 10.1038/jp.2017.106.
    1. Mangat AK, Schmölzer GM, Kraft WK. Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS) Semin Fetal Neonatal Med. 2019 Apr;24(2):133–41. doi: 10.1016/j.siny.2019.01.009.
    1. Velez M, Jansson LM. The Opioid dependent mother and newborn dyad: non-pharmacologic care. J Addict Med. 2008 Sep;2(3):113–20. doi: 10.1097/ADM.0b013e31817e6105.
    1. MacMillan KDL, Rendon CP, Verma K, Riblet N, Washer DB, Volpe Holmes A. Association of rooming-in with outcomes for neonatal abstinence syndrome: a systematic review and meta-analysis. JAMA Pediatr. 2018 Apr 01;172(4):345–51. doi: 10.1001/jamapediatrics.2017.5195.
    1. Hudak ML, Tan RC, Committee on Drugs. Committee on Fetus and Newborn. American Academy of Pediatrics Neonatal drug withdrawal. Pediatrics. 2012 Feb 30;129(2):540–60. doi: 10.1542/peds.2011-3212.
    1. ACOG Committee on Health Care for Underserved Women. American Society of Addiction Medicine ACOG Committee Opinion No. 524: opioid abuse, dependence, and addiction in pregnancy. Obstet Gynecol. 2012 May;119(5):1070–6. doi: 10.1097/AOG.0b013e318256496e.
    1. Obstetric care for women with opioid use disorder. Council on Patient Safety In Women’s Health Care. [2019-06-18]. .
    1. Grossman MR, Lipshaw MJ, Osborn RR, Berkwitt AK. A novel approach to assessing infants with neonatal abstinence syndrome. Hosp Pediatr. 2018 Jan 20;8(1):1–6. doi: 10.1542/hpeds.2017-0128.
    1. Suchman N, Mayes L, Conti J, Slade A, Rounsaville B. Rethinking parenting interventions for drug-dependent mothers: from behavior management to fostering emotional bonds. J Subst Abuse Treat. 2004 Oct;27(3):179–85. doi: 10.1016/j.jsat.2004.06.008.
    1. Casper T, Arbour M. Evidence-based nurse-driven interventions for the care of newborns with neonatal abstinence syndrome. Adv Neonatal Care. 2014 Dec;14(6):376–80. doi: 10.1097/ANC.0000000000000118.
    1. Abrahams RR, Kelly SA, Payne S, Thiessen PN, Mackintosh J, Janssen PA. Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Can Fam Physician. 2007 Oct;53(10):1722–30.
    1. Wilder C, Lewis D, Winhusen T. Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder. Drug Alcohol Depend. 2015 Apr 01;149:225–31. doi: 10.1016/j.drugalcdep.2015.02.012.
    1. Burduli E, Smith CL, Tham P, Shogan M, Johnson RK, McPherson SM. Development and application of a primer and reference assessment tool for neonatal abstinence syndrome: a phase I pilot study. Contemp Clin Trials Commun. 2020 Mar;17:-. doi: 10.1016/j.conctc.2019.100494.
    1. Schreier M. The SAGE Handbook of Qualitative Data Analysis. Thousand Oaks, CA: SAGE Publications Ltd; 2014. Qualitative content analysis in practice.
    1. Sandelowski M. What's in a name? Qualitative description revisited. Res Nurs Health. 2010 Feb 10;33(1):77–84. doi: 10.1002/nur.20362.
    1. Sandelowski M. Whatever happened to qualitative description? Res Nurs Health. 2000 Aug;23(4):334–40. doi: 10.1002/1098-240x(200008)23:4<334::aid-nur9>;2-g.
    1. Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Evaluation and Program Planning. 1979 Jan;2(3):197–207. doi: 10.1016/0149-7189(79)90094-6.
    1. Bangor A, Kortum P, Miller J. Determining what individual SUS scores mean: adding an adjective rating scale. J Usability Stud. 2009. [2021-03-17].
    1. System Usability Scale (SUS) 2019. [2019-08-12]. .
    1. Attkisson CC, Zwick R. The client satisfaction questionnaire: psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann. 1982 Jan;5(3):233–7. doi: 10.1016/0149-7189(82)90074-x.
    1. Attkisson CC, Zwick R. Client Satisfaction Questionnaire-8. APA PsycTests: Citation and Description. 1982. [2021-03-17]. .
    1. Cacciola JS, Alterman AI, McLellan AT, Lin Y, Lynch KG. Initial evidence for the reliability and validity of a "Lite" version of the Addiction Severity Index. Drug Alcohol Depend. 2007 Mar 16;87(2-3):297–302. doi: 10.1016/j.drugalcdep.2006.09.002.
    1. Busonera A, Cataudella S, Lampis J, Tommasi M, Zavattini GC. Investigating validity and reliability evidence for the Maternal Antenatal Attachment Scale in a sample of Italian women. Arch Womens Ment Health. 2016 Apr 21;19(2):329–36. doi: 10.1007/s00737-015-0559-3.
    1. Condon JT. The assessment of antenatal emotional attachment: development of a questionnaire instrument. Br J Med Psychol. 1993 Jun;66 ( Pt 2):167–83. doi: 10.1111/j.2044-8341.1993.tb01739.x.
    1. van Bussel JCH, Spitz B, Demyttenaere K. Three self-report questionnaires of the early mother-to-infant bond: reliability and validity of the Dutch version of the MPAS, PBQ and MIBS. Arch Womens Ment Health. 2010 Oct 2;13(5):373–84. doi: 10.1007/s00737-009-0140-z.
    1. Mako HS. Reliability and validity of the Hungarian version of the maternal antenatal attachment scale. Int J Gynecol Obst Res. 2014 Jun;2(1):33–44. doi: 10.14205/2309-4400.2014.02.01.5.
    1. Schwerdtfeger KL, Goff BSN. Intergenerational transmission of trauma: exploring mother-infant prenatal attachment. J Trauma Stress. 2007 Feb;20(1):39–51. doi: 10.1002/jts.20179.
    1. Condon JT, Corkindale CJ. The assessment of parent-to-infant attachment: development of a self-report questionnaire instrument. J Reprod Infant Psychol. 1998 Feb;16(1):57–76. doi: 10.1080/02646839808404558.
    1. Scopesi A, Viterbori P, Sponza S, Zucchinetti P. Assessing mother‐to‐infant attachment: the Italian adaptation of a self‐report questionnaire. J Reprod Infant Psychol. 2004 May;22(2):99–109. doi: 10.1080/0264683042000205963.
    1. Burduli E, Barbosa-Leiker C, Fleming S, Hollins Martin CJ, Martin CR. Cross-cultural invariance of the Birth Satisfaction Scale-Revised (BSS-R): comparing UK and US samples. J Reprod Infant Psychol. 2017 Jul 13;35(3):248–60. doi: 10.1080/02646838.2017.1310374.
    1. Hollins Martin CJH, Martin CR. Development and psychometric properties of the Birth Satisfaction Scale-Revised (BSS-R) Midwifery. 2014 Jun;30(6):610–9. doi: 10.1016/j.midw.2013.10.006.
    1. Barbosa-Leiker C, Fleming S, Hollins Martin CJ, Martin CR. Psychometric properties of the Birth Satisfaction Scale-Revised (BSS-R) for US mothers. J Reprod Infant Psychol. 2015 Apr 10;33(5):504–11. doi: 10.1080/02646838.2015.1024211.
    1. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606–13. doi: 10.1046/j.1525-1497.2001.016009606.x.
    1. Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. Can Med Assoc J. 2012 Feb 21;184(3):191–6. doi: 10.1503/cmaj.110829.
    1. Santos IS, Tavares BF, Munhoz TN, Manzolli P, de Ávila GB, Jannke E, Matijasevich A. Patient health questionnaire-9 versus Edinburgh postnatal depression scale in screening for major depressive episodes: a cross-sectional population-based study. BMC Res Notes. 2016 Sep 27;9(1):453. doi: 10.1186/s13104-016-2259-0.
    1. Abidin RR. Parenting Stress Index. APA PsycTests: Citation and Description. 1990 doi: 10.1037/t02445-000.
    1. Barroso NE, Hungerford GM, Garcia D, Graziano PA, Bagner DM. Psychometric properties of the Parenting Stress Index-Short Form (PSI-SF) in a high-risk sample of mothers and their infants. Psychol Assess. 2016 Oct;28(10):1331–5. doi: 10.1037/pas0000257.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe